Although controversies exist regarding the relationship between visfatin and glucose homeostasis in humans, several cross-sectional studies have confirmed that plasma visfatin level increases in subjects diagnosed with obesity and T2DM8. The gene discussed is NAMPT; the disease is obesity due to melanocortin 4 receptor deficiency.